In silico docking and scoring of fragments

Drug Discovery Today: Technologies

Volumn 7, Issue 3, 2010, Pages

  Chen, Yu ^a   Pohlhaus, Denise Teotico ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE INHIBITOR; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; PROTEIN;

ARTICLE; BINDING AFFINITY; COMPUTER MODEL; DATA BASE; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG SCREENING; MOLECULAR DOCKING; SCORING SYSTEM; STRUCTURE ACTIVITY RELATION; VIRTUAL REALITY;

EID: 78650717723     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2010.11.002     Document Type: Review

References (46)

1. M. Congreve Recent developments in fragment-based drug discovery J. Med. Chem. 51 2008 3661 3680
2. M. Congreve A 'rule of three' for fragment-based lead discovery? Drug Discov. Today 8 2003 876 877
3. T. Fink Virtual exploration of the small-molecule chemical universe below 160 Daltons Angew. Chem. Int. Ed. Engl. 44 2005 1504 1508
4. J.J. Irwin, and B.K. Shoichet ZINC - a free database of commercially available compounds for virtual screening J. Chem. Inf. Model. 45 2005 177 182
5. J.W. Huang Fragment-based design of small molecule X-linked inhibitor of apoptosis protein inhibitors J. Med. Chem. 51 2008 7111 7118
6. G. Klebe Virtual ligand screening: strategies, perspectives and limitations Drug Discov. Today 11 2006 580 594
7. R.E. Hubbard Informatics and modeling challenges in fragment-based drug discovery Curr. Opin. Drug Discov. Dev. 10 2007 289 297
8. A. Miranker, and M. Karplus Functionality maps of binding sites: a multiple copy simultaneous search method Proteins 11 1991 29 34
9. M.C. Stultz, and M. Karplus Fragment-docking to proteins with the Multi-copy Simultaneous Search Methodology W. Jahnke, D.A. Erlanson, Fragment-based Approaches in Drug Discovery 2006 Wiley-VCH 125 144
10. M.R. Landon Identification of hot spots within druggable binding regions by computational solvent mapping of proteins J. Med. Chem. 50 2007 1231 1240
11. O. Guvench, and A.D. MacKerell Jr Computational fragment-based binding site identification by ligand competitive saturation PLoS Comput. Biol. 5 2009 e1000435
12. M. Clark Grand canonical Monte Carlo simulation of ligand-protein binding J. Chem. Inf. Model. 46 2006 231 242
13. D. Ekonomiuk Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics J. Med. Chem. 52 2009 4860 4868
14. K. Loving Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation J. Comput. Aided Mol. Des. 2009
15. C.W. Murray Application of fragment screening by X-ray crystallography to beta-secretase J. Med. Chem. 50 2007 1116 1123
16. P.D. Edwards Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency J. Med. Chem. 50 2007 5912 5925
17. D.G. Teotico Docking for fragment inhibitors of AmpC beta-lactamase Proc. Natl. Acad. Sci. U. S. A. 106 2009 7455 7460
18. Y. Chen, and B.K. Shoichet Molecular docking and ligand specificity in fragment-based inhibitor discovery Nat. Chem. Biol. 5 2009 358 364
19. C. Rummey In silico fragment-based discovery of DPP-IV S1 pocket binders Bioorg. Med. Chem. Lett. 16 2006 1405 1409
20. J.J. Irwin Virtual screening against metalloenzymes for inhibitors and substrates Biochemistry 44 2005 12316 12328
21. C.P. Mpamhanga One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening J. Med. Chem. 52 2009 4454 4465
22. G.F. Ruda Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase Bioorg. Med. Chem. 18 2010 5056 5062
23. M. Hohwy Novel prostaglandin D synthase inhibitors generated by fragment-based drug design J. Med. Chem. 51 2008 2178 2186
24. S. Kawatkar Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide J. Comput. Aided Mol. Des. 2009
25. R.E. Hubbard The SeeDs approach: integrating fragments into drug discovery Curr. Top. Med. Chem. 7 2007 1568 1581
26. M. Sandor Virtual fragment docking by Glide: a validation study on 190 protein-fragment complexes J. Chem. Inf. Model 50 2010 1165 1172
27. R. Law The multiple roles of computational chemistry in fragment-based drug design J. Comput. Aided Mol. Des. 23 2009 459 473
28. Y. Arendt Fragment docking to S100 proteins reveals a wide diversity of weak interaction sites ChemMedChem 2 2007 1648 1654
29. D. Huang, and A. Caflisch Library screening by fragment-based docking J. Mol.Recognit. 23 2009 183 193
30. M. Clark Fragment-based computation of binding free energies by systematic sampling J. Chem. Inf. Model. 49 2009 1901 1913
31. D.C. Thompson CONFIRM: connecting fragments found in receptor molecules J. Comput. Aided Mol. Des. 22 2008 761 772
32. J. Degen, and M. Rarey FlexNovo: structure-based searching in large fragment spaces ChemMedChem 1 2006 854 868
33. G. Schneider, and U. Fechner Computer-based de novo design of drug-like molecules Nat. Rev. Drug Discov. 4 2005 649 663
34. K. Loving Computational approaches for fragment-based and de novo design Curr. Top. Med. Chem. 10 2010 14 32
35. M.L. Teodoro, and L.E. Kavraki Conformational flexibility models for the receptor in structure based drug design Curr. Pharm. Des. 9 2003 1635 1648
36. H.A. Carlson, and J.A. McCammon Accommodating protein flexibility in computational drug design Mol. Pharmacol. 57 2000 213 218
37. B.Q. Wei Testing a flexible-receptor docking algorithm in a model binding site J. Mol. Biol. 337 2004 1161 1182
38. K.L. Damm A poke in the eye: inhibiting HIV-1 protease through its flap-recognition pocket Biopolymers 89 2008 643 652
39. A.P. Graves Rescoring docking hit lists for model cavity sites: predictions and experimental testing J. Mol. Biol. 377 2008 914 934
40. N. Huang, and B.K. Shoichet Exploiting ordered waters in molecular docking J. Med. Chem. 51 2008 4862 4865
41. A.C. English Experimental and computational mapping of the binding surface of a crystalline protein Protein Eng. 14 2001 47 59
42. J. Tirado-Rives, and W.L. Jorgensen Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding J. Med. Chem. 49 2006 5880 5884
43. M.P. Gleeson, and D. Gleeson QM/MM as a tool in fragment based drug discovery. A cross-docking, rescoring study of kinase inhibitors J. Chem. Inf. Model. 49 2009 1437 1448
44. G. Marcou, and D. Rognan Optimizing fragment and scaffold docking by use of molecular interaction fingerprints J. Chem. Inf. Model. 47 2007 195 207
45. R. Friedman, and A. Caflisch Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoring ChemMedChem 4 2009 1317 1326
46. S.E. Boyce Predicting ligand binding affinity with alchemical free energy methods in a polar model binding site J. Mol. Biol. 394 2009 747 763